AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05006638 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toxogonin
Description: a drug used as an antidote for some types of pesticides
Study NCT05006638 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Toxogonin
Description: a drug used as an antidote for some types of pesticides
Study NCT05006638 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Bicarbonate Powder and ondansetron
Description: standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide
Study NCT05006638 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium Bicarbonate Powder and ondansetron
Description: standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide
Study NCT06038643 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational behavioural intervention and daily activities monitoring
Description: Social motivation manipulation, self-transcendence daily messaging, and daily activities monitoring through accelerometry. Participants in this arm will have a study partner who receives daily feedback on the main participant's daily step count.
Study NCT06038643 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Daily activities monitored through accelerometry.
Study NCT06418802 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: STN-DBS surgery
Description: bilateral subthalamic nucleus deep brain stimulation surgery
Study NCT06418802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: STN-DBS surgery
Description: bilateral subthalamic nucleus deep brain stimulation surgery
Study NCT06418802 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: pulse width
Description: a short pulse width (30s)
Study NCT06418802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pulse width
Description: a short pulse width (30s)
Study NCT06418802 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: frequency
Description: frequency parameters of STN-DBS (60,100, and 130HZ)
Study NCT05205057 — intervention group
Intervention type: OTHER
Intervention: Saliva
Description: Unstimulated whole saliva is collected
Study NCT06450756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couples arm
Description: The Couples Arm aims to improve family planning (FP) utilization in pastoralist communities, addressing significant disparities in contraceptive use and unmet FP needs between pastoralist and agrarian communities in Ethiopia. Pastoralist areas face challenges such as low contraceptive usage, high unmet FP needs, and elevated rates of maternal and child morbidity and mortality. In 2016, only 9.1% of women in pastoralist areas used contraceptives, compared to a 41% prevalence rate in 2019 for the general population in Ethiopia. Reasons for non-use of contraceptives include lack of knowledge, unwillingness, negative perceptions, desire for many children due to child mortality concerns, and male dominance in FP decision-making. The study hypothesizes that engaging men and educating women about FP could enhance FP utilization, increase male involvement in family planning, and empower women.
Study NCT06450756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Male arm
Description: This arm focused on promoting male involvement in family planning (FP) through comprehensive health education and video messages. Husbands were encouraged to become supportive partners and share FP information with their wives. Separate education sessions were held for men, recognizing their greater exposure to social activities and information in pastoralist contexts. Pastoralist wives typically rely on their husbands for information due to limited social access. Women in pastoral communities have significant informal power in family decisions, influenced by factors such as age, husband's status, sons' ages, eloquence, and wisdom. Reproductive health discussions are primarily between husband and wife. Education aimed to improve modern contraceptive use, overcoming common barriers like husband objection and religious influence on decision-making.
Study NCT06071403 — intervention group
Intervention type: OTHER
Intervention: (enteral feeding volume/ total fluid volume)*100%
Description: (enteral feeding volume/ total fluid volume)\*100%. Total fluid volume is defined as enteral feeding volume + parenteral fluid volume + other fluid volume
Study NCT04985890 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UB-421
Description: 10mg/kg weekly intravenous infusion to substitute for for antiretroviral therapy
Study NCT04985890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UB-421+chidamide
Description: 10 mg/kg UB-421 weekly intravenous infusion to substitute for antiretroviral therapy, and combined with oral 10 mg chidamide twice a week for 8 weeks. Chidamide taken on the one day and three days after the administration of UB-421.
Study NCT05003713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CORT125236
Description: CORT125236 Lipid Capsule Formulation 10-60 mg for oral administration
Study NCT05003713 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching CORT125236
Description: Placebo matching CORT125236 Lipid Capsule Formulation 10-60 mg for oral administration
Study NCT05003713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone tablet 25 mg (20 mg + 5 mg tablets) for oral administration
Study NCT04980508 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: corpus cavernosum electromyography
Description: Cc-EMG was performed by using the cc-EMG module of Ellipse 4 device (Andromeda, Germany), which comprises of a 2-channel electromyography amplifier with a row sampling rate of 16 kHz, filtered sampling rate of 166.67 Hz and a band width of 0.5-30 Hz with the speed of the thermo-writer paper set at 5 mm/s. Measurements of the electrical activity of the corpus cavernosum (EACC) were done for 10 minutes using coaxial needle electrodes during the flaccid state and after intracavernous papaverine (60 mg) injection.
Study NCT05245409 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic adjustment using an activator
Description: Chiropractic adjustment using an activator
Study NCT04283981 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control group without use of VSP
Description: The control group will include patients that undergo mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) in standard fashion (without virtual surgical planning assistance and occlusal splint)
Study NCT04283981 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment Group with use of VSP
Description: The treatment group corresponds to patients undergoing mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) utilizing virtual surgical planning via 3D Systems, bite registration and fabrication of occlusal splint via intraoral digital scanner, and mandibular hardware
Study NCT06101953 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress management
Description: It spanned 12 weeks, with three hours per week (comprising two hours of theoretical content and one hour of practical application) and employed diverse teaching methods, including lectures, interactive learning, research, fieldwork, hands-on practice, and question-answer sessions. The primary objective of this course was to enhance students' awareness of stress by helping them identify its sources, symptoms, and effects. Also interception and resilience. Furthermore, it aimed to teach students how to assess stress and apply stress-management techniques effectively in their daily lives.
Study NCT05302934 — intervention group
Intervention type: DEVICE
Intervention: Pheno4U
Description: Total Knee Arthroplasty represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or other indications resulting in joint destruction. In general, Implantation of a total knee prosthesis improves the quality of life through pain alleviation, deformity correction, joint stabilization, and/or functional range of motion (ROM) through restoration of normal knee kinematics and functionality
Study NCT06164301 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Elemental amino-acids
Description: mono peptide oral protein formula
Study NCT06164301 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Elemental amino-acids
Description: mono peptide oral protein formula
Study NCT05207735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: * Sintilizumab, 200 mg, intravenous infusion, a treatment cycle every 3 weeks, administration on the first day of each cycle, 6 cycles.~* Capecitabine: 1250 mg/m2, orally, twice a day, 1-14 days, one treatment cycle every three weeks, 8 cycles.
Study NCT05276557 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: PyloPlus Urea Breath Test System
Description: System containing a kit containing 13C urea and breath collection bags, and an analyzer to test breath samples pre and post 13C ingestion.
Study NCT05276557 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Stool Antigen Test
Description: An antigen test performed via a laboratory to test patients' stool for H. pylori
Study NCT05196581 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dispersible NaCl powder 10 sessions
Description: Dispersible NaCl powder 10 sessions
Study NCT06418802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: frequency
Description: frequency parameters of STN-DBS (60,100, and 130HZ)
Study NCT05196581 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dispersible NaCl powder 5 sessions
Description: Dispersible NaCl powder 5 sessions
Study NCT05969496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib
Description: Axitinib is a potent oral, vascular endothelial growth factor, c-kit and platelet derived growth factor inhibitor.
Study NCT06470802 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Familiar voice
Description: The recording is provided to the patient through a smartphone with a music player application, using noise-free Bluetooth earphones for 15 minutes per session, twice daily (morning and afternoon shift), for 7 consecutive days.~Each session is separated by at least a 2-hour interval
Study NCT06470802 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nature sounds
Description: The recording is provided to the patient through a smartphone with a music player application, using noise-free Bluetooth earphones for 15 minutes per session, twice daily (morning and afternoon shift), for 7 consecutive days.~Each session is separated by at least a 2-hour interval
Study NCT06470802 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control
Description: The recording is provided to the patient through a smartphone with a music player application, using noise-free Bluetooth earphones for 15 minutes per session, twice daily (morning and afternoon shift), for 7 consecutive days.~Each session is separated by at least a 2-hour interval
Study NCT05490979 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contemplative dyad meditation
Description: Participants take part in a 3-hour group meditation training led by a professional meditation teacher. They receive detailed instructions and also practice contemplative dyad meditation for at least 30 minutes with another participant. During the 2 weeks following the training, participants meet in supervised group settings to practice the meditation method with alternating partners for up to 6 times.
Study NCT05490979 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Fast friends
Description: During 2 weeks, participants meet in supervised group settings to practice the 'fast friends' exercise with alternating partners for up to 6 times.
Study NCT05737043 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: prenatal diagnose
Description: we will do a fetal echo in pregnant women with polyhidramnios
Study NCT05737043 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: prenatal diagnose
Description: we will do a fetal echo in pregnant women with polyhidramnios
Study NCT06335992 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise regime
Description: Exercise
Study NCT05969496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab is a type of immunotherapy. It stimulates the body's immune system to fight cancer cells. Pembrolizumab targets and blocks a protein called PD-1 on the surface of certain immune cells called T-cells. Blocking PD-1 triggers the T-cells to find and kill cancer cells.
Study NCT05717426 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Open chain exercises
Description: An open chain exercise is one that allows the furthest part of the chain to move freely. For example, picking up a glass of water is an open-chain exercise. The hand affects the elbow and the shoulder as it is not fixed in place. However, it does not effect the rest of your body.
Study NCT05717426 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Closed kinetic chain exercises
Description: Closed Kinetic Chain (CKC) exercises or closed chain exercises are exercises or movements where the distal aspect of the extremity is fixed to an object that is stationary.
Study NCT05172167 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Levels of IgG and IgM SARS-CoV-2 antibodies blood test.
Description: 0,1,2 months
Study NCT05172167 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: RT-PCR SARS-CoV-2 nasopharyngeal swab
Description: 0,1,2 months
Study NCT05114915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-bound docetaxel
Description: Albumin-bound docetaxel by intravenous infusion
Study NCT06062225 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kamikawa
Description: Kamikawa reconstruction after proximal gastrectomy
Study NCT06062225 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: STJI
Description: Single-Tract Jejunal Interposition(STJI) reconstruction after proximal gastrectomy
Study NCT06062225 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SOFY
Description: SOFY reconstruction after proximal gastrectomy
Study NCT04450654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gamunex-C
Description: Gamunex-C IVIG will be given at week 0 and week 4
Study NCT04450654 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Albumin
Description: 1% albumin solution dosed at equivalent volume to the corresponding weight-based Gamunex-C IVIG dose will be given at week 0 and week 4
Study NCT05978284 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ZG006
Description: ZG006 will be administered as an intravenous (IV) infusion.
Study NCT05206695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-condition Pathway Intervention
Description: See Experimental/Arm 1 description
Study NCT04907695 — intervention group
Intervention type: DEVICE
Intervention: I View Video Laryngoscope https://www.intersurgical.com/content/files/108253/-1977057700
Description: All intubations will be performed at the direction of the attending clinician. The decision to intubate is based purely on clinical factors by the primary team. The decision to use VL device will be at the direction of the clinical team. No patient will be recruited specific for this procedure.
Study NCT06052150 — intervention group
Intervention type: PROCEDURE
Intervention: Dental exam and periodontal cleaning if needed
Description: Dental exam and periodontal cleaning if needed
Study NCT05323084 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplement
Description: 1 week of each intervention at bedtime with a 2-week washout period in between interventions
Study NCT05323084 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary supplement
Description: 1 week of each intervention at bedtime with a 2-week washout period in between interventions
Study NCT04695496 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theta bust stimulating
Description: Theta burst stimulation with Magstim super rapid 2, over SMA. 3 section per day, for 5 days, total 15 sections.
Study NCT06651619 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water
Description: Prescribed amount of bottled water the evening prior and 2 hours prior to team practice
Study NCT06651619 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydration Education
Description: 30-60 minutes
Study NCT05419375 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Screening platform
Description: The screening platform will be used to determine biomarker eligibility for a linked Roche study based on tissue-based testing.
Study NCT06415838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Activation
Description: A five-session brief behavioral activation treatment delivered face-to-face in the participants' home.~Session outline:~Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log~Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week~Session 3: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week.~Session 4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for the coming week; instructing the participant to independently continue to plan activities for the coming month.~Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned with life goals and values; creating a maintenance plan.
Study NCT06415838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care as Usual
Description: Care as Usual provided by primary care and/or municipal care.
Study NCT06415838 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Care as Usual
Description: Care as Usual provided by primary care and/or municipal care.
Study NCT05883540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lysergic Acid Diethylamide Tartrate
Description: 25 μg p.o.
Study NCT05883540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide Tartrate
Description: 100 or 200 μg p.o.
Study NCT05987397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: idebenone 30 mg for 14 days
Description: The patient received oral idebenone 30 mg three times a day after stroke for a total course of 14 days (acute phase).
Study NCT05987397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: idebenone 30 mg for 3 months
Description: The patient will be treated with oral idebenone 30 mg three times a day after stroke for a total course of 3 months.
Study NCT06017141 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection
Study NCT06017141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection
Study NCT06017141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electronic Health Record Review
Description: Ancillary studies
Study NCT06017141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Ancillary studies
Study NCT06017141 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Citrate
Description: Given via injection
Study NCT06017141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Citrate
Description: Given via injection
Study NCT06017141 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Given IV
Study NCT06017141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Given IV
Study NCT06017141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06017141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06017141 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Given via inhalation
Study NCT06017141 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical Procedure
Description: Undergo SOC surgery
Study NCT06017141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Procedure
Description: Undergo SOC surgery
Study NCT05427721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thymol
Description: 200 mg each 8 hours for 90 days
Study NCT05427721 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Thymol
Description: 200 mg each 8 hours for 90 days
Study NCT05823701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: 20 mg (4 capsules), d1, d4, d8, d11 orally per cycle
Study NCT05823701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: 100mg d1- d5 subcutaneous injection per cycle
Study NCT05823701 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: obinutuzumab
Description: 1000mg d4 intravenous infusion per cycle
Study NCT05823701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal mitoxantrone
Description: 20mg/m2 d5 intravenous infusion per cycle